Law360, New York (July 27, 2011, 1:45 PM ET) -- Johnson & Johnson asked the Federal Circuit last week to rehear its appeal of a decision in favor of Boston Scientific Corp. that deemed four J&J patents for drug-eluting stents invalid for lack of adequate written description.
In a petition for rehearing or rehearing en banc lodged on July 21, J&J contends that a Federal Circuit panel erred when it concluded in June that a Delaware federal court had properly granted summary judgment to BSC because it had correctly ruled that the four patents did not...
J&J Seeks Fed. Circ. Rehearing On Stent Patents
To view the full article, take a free trial now.
